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INTRODUCTION 
Sexually transmitted infections (STIs) are an important cause of 
morbidity and mortality worldwide, especially in women and children 
particularly in resource poor settings of developing world. 
The World Health Organization (WHO) estimates that around 340 
million new cases of STIs occurs world wide.1   50% of new cases of 
STIs occur in South East Asia. STIs most commonly affect people aged 
15 to 44 years, the most economically productive age. 
Many STIs are asymptomatic or people are reluctant to seek health 
care due to stigma attached to it. Women of child bearing age are at 
particular risk of sequelae from STIs due to the impact of many STIs on 
their reproductive health.2 Burden of STIs is not only due to acute episode 
of the infections, but it has long term and severe sequelae like infertility, 
ectopic pregnancy and pelvic inflammatory diseases. Both ulcerative and 
non ulcerative STIs enhance the risk of acquiring and transmitting HIV 
infection by five to ten folds. 2 
`Infections in pregnancy are common but few cause fetal infection 
and damage, particularly urgent is the need to control fetal wastage and 
congenital abnormalities due to maternal sexually transmitted infections 
including HIV.3 Pregnancy is vulnerable time for women. Hence STIs in 
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the pregnant women are more serious than in non pregnant women. Risk 
factors like multiple sex partners may independently affect pregnancy 
outcome. 1 
Adolescent sexual activity is increasing globally. With the change 
in social norms, peer pressure and media influences, teenagers are 
engaging in premarital sex earlier leading to unintended pregnancy and 
STIs.3  In general, sexually transmitted infections appears to pose a much 
greater problem in pregnant adolescents than in older pregnant women 
due to their monogamous relationship.  Infections in young adult have 
their most serious consequences later in life. Adolescents have 
miscarriages more often and are partly attributable to STI. Teenage 
pregnancy remains common in many societies. The incidence of Medical 
termination of Pregnancy is particularly high among adolescents. 
Violence and sexual abuse by men is another aspect where women 
and girls are the most frequent victims.3 Pregnancy may also be a sign of 
ongoing sexual abuse. Meticulous examination should be performed 
looking carefully for STIs in those cases. 
Physiological changes, anatomical changes in the genital tract, 
immunological alteration in a pregnant woman have been postulated to 
influence the course of STIs which pose special risk of infection for both 
mother and fetus.4 
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Pregnancy modifies the manifestation of many STIs and presents 
unique problems for diagnosis and management. Antenatal attendees are 
a section of population routinely used as a reference point for STI 
prevalence in the general population of women. Thus routine screening 
and treatment of certain genital infections in high risk population 
eventually may lead to reduction in adverse pregnancy outcomes. 
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REVIEW OF LITERATURE 
SEXUALLY TRANSMITTED INFECTIONS IN PREGNANCY 
 
PHYSIOLOGICAL CHANGES DURING PREGNANCY 
Immunologically T-Lymphocytes are reduced in number in 
peripheral blood samples. Decrease in CD-4 T helper subset to nearly half 
the pregnancy level which is the maximum during the third trimester. No 
significant change in CD-8 subset. Humoral substances that potentially 
suppress in vitro lymphocyte function are present in plasma.  And this 
leads to impaired response to microbial antigens and phytohemagglutin.5 
Suppressed maternal immunocompetence leads to higher attack rate of 
candidiasis. Incidence and severity of viral hepatitis are increased in 
pregnancy.6 Susceptibility to renal infection increases during pregnancy 
due to changes in ureterovesicular muscular tone induced by higher levels 
of progesterone or partial ureteral compression by gravid uterus. 
Anatomical changes include hypertrophic and engorged vaginal 
walls. Glycogen content of vaginal epithelium increases and intravaginal 
pH decreases significantly.4 These changes influence vaginal micro flora. 
The cervix becomes hypertrophic and larger area of columnar 
epithelium as exocervix is exposed to micro organisms. But cervical 
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mucous plug limit the access of microorganisms into the uterus. Risk of 
salphingitis decreases during pregnancy after 12th week and risk of  
chorioamnionitis increases after 16th week of gestation.7 
Placental trophoblastic epithelium with langhans layer and 
syncytiotrophoblast regulate fetal uptake of many substances. Placental 
macrophages or Houfbauer cells acts as first line of fetal defense to 
transplacental infection. 
SYPHILIS IN PREGNANCY 
Syphilis is a systemic, chronic infectious disease transmitted 
through sexual intercourse, from mother to infant during pregnancy and 
through transfusion of infected blood.8 Syphilis in pregnancy is a major 
cause of fetal and neonatal loss in developing countries. 
`Spirochetal transmission still occurs as a result of untreated, 
inadequately treated or failed treatment of syphilis in the mother. 
About 9,00,000 gestations occur annually among 6 million infected 
woman worldwide.9  Increasing number of congenital syphilis have been 
reported from Asian and African countries.10 Prevalence of syphilis 
seroreactivity among pregnant woman varies from 0.02 to 12.1%in 
different parts of world. 11 
Syphilis may be acquired in pregnancy or preexist in any of its 
clinical stages.12 The clinical presentation of syphilis is not significantly 
altered by pregnancy; in fact the manifestations of primary and secondary 
 6
syphilis may be milder during pregnancy due to immunosuppression.13,14 
Primary syphilis follows incubation period of 10 to 90 days. 
Primary lesions are smaller size or be so located as to go unnoticed. 
Cervical chancre is more common due to easily inoculable friable cervix. 
Increased tissue vascularity contributes toward non formation of primary 
chancre as it prevents epithelial breakdown. 15 
After 4 to 10 weeks of healing of primary chancre, secondary 
syphilis appears with variable skin rash. In 25% of patients it may go 
mild and unnoticed. Consequences of in utero infection depend on factors 
such as maternal stage, duration of pregnancy at the time of infection and 
adequacy of treatment.16 
Risk of congenital syphilis is high during first four years after 
acquisition. Rate of transmission to the fetus in untreated women is 
approximately 70 to 100% in primary and secondary syphilis, 40% in 
early latent syphilis and 10% in late latent stage.16 
Kassowit's law states that risk of congenital syphilis is inversely 
related to the duration of untreated maternal infection. Fetal infection 
with Treponema pallidum can occur as early as 9 weeks of gestation. 9 
Pathogenesis of congenital infection depends on immune response 
of fetus and not due to cytopathic effects of Treponema pallidum.14 The 
devastating effects of maternal syphilis on the fetus are many. Untreated 
maternal syphilis may lead to spontaneous abortion (most common), still 
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birth, prematurity, perinatal death and congenital syphilis. Overall it is 
estimated that one third of syphilis seroreactive pregnancies will result in 
fetal wastage, one third in the birth of infant with congenital syphilis and 
one third in the delivery of healthy uninfected child.12 
Recently syphilis is becoming leading cause of non immune 
hydrops fetalis.16 Adverse pregnancy outcome due to syphilis is 
preventable by screening and early treatment of both partners. 
VDRL screening should be done at first prenatal visit and repeated 
at third trimester in high risk patients. As reagin test lack specificity, 
specific test like Fluorescent Treponemal Antibody absorption test or 
Treponema Pallidum Haemagglutionation Assay for antibodies to 
Treponema pallidum is used to confirm positive results. 
Women with an epidemiological history of recent exposure to an 
individual with proven syphilis should be treated regardless of serological 
results. Prior to syphilotherapy, all women should be offered counselling 
to undergo testing for antibodies to HIV. 
Penicillin therapy during pregnancy is 98% effective in preventing 
congenital infection.17 The Jarisch-Herxiheimer reaction commonly 
occurs during treatment of acquired early syphilis. Patients who do not 
show four fold drop in titre at 30 months or four fold rise in titre should 
be retreated. 
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GONORRHOEA IN PREGNANCY 
Prevalence of gonococcal infection during pregnancy ranges from 
0.5 to 7%. 18  In European countries prevalence is below 1%. 
Risk factors for acquisition of gonococci include being single, 
adolescent, poverty, drug abuse, prostitution, lack of prenatal care. 
Gonococcal infection is also a marker of concomitant chlamydial 
infection in about 40% of infected pregnant women. 
More than half of the pregnant women with gonococcal infection 
are asymptomatic and clinical signs are associated with this infection is 
not sufficiently sensitive or specific. 12 
Several studies have reported an increased risk of pharyngeal 
gonorrhea to about 15 to 35%.  And this pharyngeal gonorrhoea also 
increases risk of disseminated gonococcal infection in pregnancy 
particularly in the second and third trimester.18  
Increased gonococcal dissemination could be due to engorged 
pelvic vasculature or altered immune status of pregnancy. 
Gonococcal infection is limited to lower genital tract including 
cervix, urethra, periurethral and vestibular gland in most pregnant 
women. Endocarditis rarely complicates pregnancy. 
Gonococcal salphingitis have been reported between 7 and 12th 
week of gestation. 19  Pelvic inflammatory disease is rare event during 
pregnancy. Local cervical factors and increased serum progesterone 
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concentration decreases the risk of ascending infection during pregnancy. 
Gonorrhoea has adverse effect upon both mother and child. 
Maternal complications are spontaneous or septic abortions, premature 
rupture of membranes, postpartum endometritis.15 Increased risk of 
prematurity, low birth weight, gonococcal ophthalmia neonatorum are the 
most important perinatal complication.19 
Neonates can present with bilateral mucopurulent conjunctivitis, 
corneal ulcer, perforation, anterior staphyloma, anterior capsular cataract, 
and panophthalmitis. Risk of amniotic fluid infection syndrome and 
gonococcal ophthalmia appears to be increased after premature rupture of 
membranes. 19 
Neonates can have gonococcal meningitis, arthritis, septicemia, 
rarely neonatal vaginitis20, endocarditis, anorectal infection, funisitis and 
urethritis. 21   Gonococcal scalp abscess can occur at scalp electrode site. 
The gold standard diagnostic test for gonococcal infection in 
women is endocervical culture. But this is neither available nor practical 
in most antenatal care settings. All pregnant women should be screened 
for infection during first visit and repeat cultures at 36 to 38 weeks in 
high risk population..22 
All patients treated during pregnancy should have repeat cultures in 
the third trimester and for those patients whose partners have not been 
treated. Nucleic acids amplification assays for the detection of 
 10
gonorrhoea and Chlamydia trachomatis are more sensitive for screening 
urine and cervical samples, but not available easily due to its high cost. 
 
CHANCROID IN PREGNANCY 
Chancroid is seen less common in women.21   It appears that 
women are asymptomatic carriers.22 
The disease has no influence on pregnancy outcome and the 
disease is not yet reported in neonates. Hemophilis ducrey causes painful 
non-indurated genital ulcer or soft sore and at times accompanied by 
painful inguinal lymphadenopathy. Chancroidal infection is a high risk 
factor for HIV and syphilis transmission. 
Diagnosis by culture is difficult because appropriate media are not 
widely available. Instead clinical diagnosis is made when typical painful 
genital ulcers are present with negative dark field examination and herpes 
viral test. 
 
GRANULOMA INGUINALE IN PREGNANCY 
Vagina is often infected with autoinoculation with 
Calymmatobacterium granulomatis, as the organism has fecal habitat. 
Prevalence of granuloma inguinale is very low and about less than 
1% in STI clinic attendees. 
Lesions of Donovanosis tend to proliferate or recur and show 
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diminished response to standard antimicrobial therapy.23 Cervical lesions 
rapidly enlarge, extend to pelvic structures and disseminate resulting in 
fatal hemorrhage at the time of delivery. The hypertrophic variant is more 
commonly seen during pregnancy, But these effects could not be 
established according to a South African study.24 Miscarriage and 
abortion due to Granuloma inguinale are rarely reported. 
Perinatal transmission has occasionally reported in untreated 
patients and manifest as suppurative otitis media, cervical 
lymphadenopathy, lesions on umbilicus, labia and penis.25,26,27 
 
LYMPHOGRANULOMA VENEREUM IN PREGNANCY 
Lymphogranuloma venereum caused by L1, L2, and L3 serovars of 
Chlamydia trachomatis is characterized by transient primary genital 
infections and followed by inguinal adenitis. 
The course and diagnosis of lymphogranuloma venereum are not 
known to be altered by pregnancy. 
There is little evidence of transplacental or perinatal transmission, 
but no problems have been recognized in babies.27 Infection may be 
acquired through infected birth canal.28 
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CHLAMYDIA TRACHOMATIS INFECTION IN PREGNANCY 
Chlamydia trachomatis is the most common sexually transmitted 
disease in women of reproductive age.12 The rate of Chlamydial infection 
among pregnant women ranges from 2 to 20%.29 Rate of isolation of the 
organism is higher during third trimester. 
Among pregnant women risk factors for chlamydia infection 
includes unmarried status, age below 20years. presence of other STIs, 
partners with non gonococcal uretheritis, presence of mucopurulent 
cervicitis, sterile pyuria, resident of socially disadvantaged community, 
late or no prenatal care.10,15 
Up to 70% of women infected with chlamydial infections may be 
asymptomatic or experience subclinical symptoms.30 Cervical 
colonization is present in 3 to 25% of pregnant patients. 
There is transplacental transfer of maternal IgG antibodies as early 
as day 38, but not completely protective. Organism causes several clinical 
syndromes including uretheritis, mucopurulent cervicitis, and acute 
salphingitis. Upper genital tract infections are rare in pregnancy. Maternal 
infection present as bartholinitis, perihepatitis, conjunctivitis and reactive 
arthritis. 
Fetal wastage approaches 50% in gestational pelvic inflammatory 
diseases.12 It produces chronic cervical infection. There is high co- 
infection rate of Chlamydia with gonorrhoea in pregnant population. 
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Studies have shown association between chlamydial infection in 
pregnancy and adverse pregnancy outcomes such as spontaneous 
abortion, premature rupture of membranes, preterm labour, low birth 
weight infants and delayed post partum endometritis. 12,31 
The risk of vertical transmission in untreated genital infection 
approaches 70% as documented by seroconversion in infant.12 Infection 
occurs during passage of infant through an infected birth canal resulting 
in ophthalmia neonatorum, pneumonia, serous otitis media.27 
Increased number of WBCs occur in the cervix in normal pregnant 
women, hence the diagnosis of mucopurulent cervicitis does not correlate 
well with the presence of Chlamydia in pregnancy and cannot be used as 
a screening tool.32 
The gold standard method of diagnosis is cell culture which is not 
universally available. Centre for disease control recommends screening of 
all pregnant women less than 25 years old or those who have new or 
multiple sex partners. Repeat cultures in third trimester were 
recommended in those who are at high risk. 
Greater importance should be given for screening unmarried 
women less than 20 years of age before medical termination of 
pregnancy, or delivery. DNA probe assay and enzyme immuno assay 
have greater sensitivities in detection. Newer nucleic acid amplification 
tests are much more sensitive in screening pregnant women. 
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VULVOVAGINAL CANDIDIASIS IN PREGNANCY 
Candidal vaginal infections are classically considered with other 
STIs. Candida albicans is present in the vagina of approximately 25% of 
sexually active women. 
Symptomatic vaginal candidiasis affects 15% of pregnant women. 
About 10% of women in the first trimester and 36 to 50% of patients in 
the third trimester have symptomatic disease. 33  Vulvovaginal candidiasis 
is recurrent in 8% of women in the reproductive age. 34 
Clinical signs of infection could be detected in all pregnant women 
from whom the fungus was isolated, even in those without symptoms.34 
Increase in glycogen content of vaginal epithelial cells and 
vascularity predisposes to candidal infection in pregnancy. Proteinases 
along with hyphal invasion cause swelling, erythema, desquamation, 
exfoliation and acute inflammatory response. 
Severe vulval pruritus is the most common symptom. Vulvovaginal 
candidiasis manifest as edematous vulva with fissuring between intra 
vulval folds and thick curdy white discharge adherent to introitus and 
vestibular area. Occasionally there may be rash with satellite micro 
pustules around outer labia and involvement of perianal area. There is 
increase in the prevalence of vaginal candidiasis in women infected with 
HIV. 35 
There are rare case reports of intrauterine acquired candidiasis 
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(ascending vaginal infection) resulting in spontaneous abortion.36 Also 
there are occasional case reports of candidal chorioamnionitis.22 
The most common route of perinatal infection is by direct contact 
during delivery through an infected vagina and oral thrush of the neonate 
is the most common problem.28 So the prepartal vaginal colonization 
should be treated to protect the newborn. 
The clinical appearance is confirmed by gram staining, KOH 
mount and culture. Gram staining shows diagnostic pseudo hyphae in 30 
to 50% of cases. Culture in sabouraud's dextrose agar (most commonly 
employed) or chrom agar medium is even more sensitive.28 
 
TRICHOMONIASIS IN PREGNANCY 
Trichomoniasis is the most common protozoal STI and is isolated 
with many perinatal complication, male and female genitourinary tract 
infections and an increased incidence of HIV transmission.37 
Prevalence of Trichomonas vaginalis infection in pregnancy has 
ranged from 3 to 10% from several antenatal clinics.38 Factors associated 
with Trichomonas infection are black race, cigarette smoking, unmarried 
females, less education, a history of gonorrhoea, multiple sex partners. 
Vaginitis is usually asymptomatic and characterized by purulent 
greenish yellow frothy vaginal discharge, vulvovaginal erythema and 
strawberry cervix. Trichomoniasis has been associated with increased risk 
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of preterm delivery, maternal puerperal infection, premature rupture of 
membranes.39,40 
Due to combination effect of organism, proteases and host 
inflammatory response there is decrease in elasticity leading to rupture 
and bursting of chorioamniotic membranes.41 
  Due to the estrogenic effect during pregnancy, vaginal mucosa of 
female neonates is susceptible to infection. This is reversed 
spontaneously within 3 to 4 weeks after delivery. Risk of neonatal 
infection in exposed neonates is 5%. Purulent vaginitis, urinary tract 
infection and neonatal pneumonia have been described.41 
Wet mount examination for trichomonads is positive only in 50% 
of infected women. These findings are unaltered by pregnancy, except for 
an increase in the number of WBCs in the vaginal fluid.10 
Vaginal culture is more sensitive than direct microscopy of vaginal 
secretions. Screening of all pregnant women who are at increased risk of 
preterm birth should be done with wet mount and culture. Trichomonal 
infection suspected on papanicolaou smear of the cervix should be 
confirmed by wet mount and culture before treatment during pregnancy. 
 
BACTERIAL VAGINOSIS IN PREGNANCY 
Bacterial vaginosis is a polymicrobial imbalance of vaginal flora.42 
Bacterial vaginosis is detected in 12 to 23% of pregnant women, 
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increasing to more than 30% in women who deliver prematurely.43 
Pregnant black women and unmarried are especially at higher risk.  
Half the populations of women with bacterial vaginosis are 
asymptomatic and current standard antenatal procedures do not provide 
regular screening for bacterial vaginosis.44 
Bacterial vaginosis is characterized by nonpurulent, homogenous, 
malodorous vaginal discharge and by an increase in vaginal pH and by 
the presence of characteristic amines and organic acids in the vaginal 
fluid. 
Bacterial vaginosis increases the risk of post operative infections, 
and acquisition of HIV and other STIs because of lack of peroxidase 
producing lactobacilli which allow local cytokine production. 
Bacterial vaginosis increases the risk of maternal and fetal 
morbidity. Bacterial vaginosis is associated with adverse sequelae such as 
spontaneous abortion, premature rupture of membranes, preterm labour, 
intrauterine infections (choroiamnionitis), postpartum endometritis, low 
birth weight babies, neonatal sepsis and cutaneous abscess, congenital 
pneumonia, jaundice of the newborn 43, 45, 46 
Early detection by gram staining and clinical criteria is easy and 
inexpensive. For the interpretation of Bacterial vaginosis, Nugent’s 
criteria was used. Bacterial groups proposed are 1.large gram positive 
rods(lactobacilli) 2. small gram negative or variable rods (Gardenella 
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vaginalis or Prevotella spp) 3. curved gram negative or variable rods 
(Mobilincus spp). Each group is quantitatively weighted on a scale of 0 to 
4.    
Score 0 = no morphotype per oil field 
Score 1 = less than one morphotype per field 
Score 2 = one to four morphotype per field 
Score 3 = five to thiry morphotype per field 
Score 4 = more than thirty morphotype per field.  
A total score of 7 to 10 is considered to be indicative of Bacterial 
vaginosis.  
 Systemic antimicrobial therapy for bacterial vaginosis is necessary 
to prevent these complications. 43,46 
 
GENITAL HERPES IN PREGNANCY 
The incidence of genital herpes is increasing worldwide and at 
present, Herpes simplex virus type 2   is the most common cause of 
genital ulceration all over the world.7 Antenatal cases infected with 
herpes simplex virus differs considerably according to the incidence of 
STI in the area, but it is roughly 1%. According to various reports from 
developed countries the attack rate per 100 pregnancies for herpes 
simplex virus is 12%.21 
Primary herpes simplex virus is symptomatic in only one third of 
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cases, mostly mild and asymptomatic.47  Systemic dissemination of 
herpes virus leading to hepatitis, encephalitis, pneumonia is mostly 
associated with primary herpetic infection.10 Maternal mortality with 
systemic herpetic infection in pregnancy is high. 
Up to 80% of pregnant women with genital herpes simplex virus 
infection have recurrences during pregnancy, on an average 2 to 4 times 
more frequently in the third trimester.10, 12  Cervical involvement is less 
frequent with recurrent infection.  
Recurrences in pregnancy will be asymptomatic in 10% and 
frequently involve perineum, buttock, back and thighs and this allows 
consideration for vaginal delivery. 
Acquisition of genital herpes during pregnancy has been associated 
with spontaneous abortion, premature labour, intrauterine growth 
retardation, fetal death, congenital and neonatal herpes.10 
Frequency of these complications is higher with first episode of 
herpetic infection. Primary infection in the first trimester may be 
teratogenic but the risk is probably minor and is not an indication for 
therapeutic abortion. 22 
Third trimester primary genital herpes infection carries a higher 
risk of fetal and neonatal involvement due to maternal viremia. 10 
The major perinatal problem is neonatal herpes infection. Herpes 
infection acquired during labour is about 90% by direct contact with 
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infected maternal genital secretions. In 5% of cases in utero (ascending 
infection or transplacental) and in another 5% of cases herpes infection is 
acquired post partum.49 
If herpes infection is present clinically the risk of neonatal infection 
is higher than from asymptomatic maternal viral shedding. Newborn 
infection presents as three forms namely asymptomatic, localised, and 
disseminated. 
The laboratory techniques used to establish an accurate diagnosis 
of herpes infection include virologic, serologic and cytological methods.21 
The gold standard diagnostic test to detect the presence of herpes 
infection has been the viral culture. But the diagnosis of herpes infection 
is still made largely on clinical grounds.36 
Under ideal circumstances routine prenatal screening for detection 
of genital herpes could be advocated in all pregnant women. Caesarean 
delivery is indicated in women with an active genital lesion at the time of 
labour. 
 
HEPATITIS B VIRUS INFECTION IN PREGNANCY 
The prevalence of chronic hepatitis B viral infection in the general 
population worldwide is 360 million out of which 78% of infected 
individuals are seen in Asia.50 HBV carrier rate in India varies from 2 to 
5%.51 
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Overall prevalence of hepatitis B surface  antigen in pregnant 
women in several Indian studies varies from 2.6 to 12%.31,52  It is 
estimated that 1.17 to 1.64% of infants out of 24 million births occurring 
annually in this country would be infected with hepatitis B virus 
perinatally. 
The chances of acquiring hepatitis infection are directly 
proportional to the number of sexual contacts and maximum positivity of 
surface antigen in the second and third trimester. 
There is no evidence that the clinical presentation or the course of 
the disease in healthy pregnant women differs from that in non pregnant 
women. 53 
Acute viral hepatitis during pregnancy may cause spontaneous 
abortion, premature labour, and intrauterine death. 22,36 However the 
major concern in pregnancy is vertical transmission to the neonate. 36 
Infection of fetus is thought to occur either by transplacental route 
or during birth process. The risk of perinatal infection is 80 to 90% when 
maternal disease occurs in the third trimester. By contrast only up to 10% 
become infected by maternal infection occurring earlier in gestation.22 
The frequency of transmission is relatively low when the mother is an 
asymptomatic carrier of hepatitis B surface antigen.36 
The risk of perinatal transmission is 10 to 20% among women who 
are HBs Ag positive and HBe Ag negative, but rises to 50 to 90% among 
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HBe antigen positive women. 22, 54 
Routine screening of pregnant women for HBs antigen is suitable 
in interrupting vertical transmission of hepatitis B viral infection. For 
high risk mothers who are antigen negative, vaccine can be provided 
during pregnancy. 
 
MOLLUSCUM CONTAGIOSUM IN PREGNANCY 
This is a common asymptomatic viral disease of vulval skin. A 
usual crop includes up to 20 lesions but hundreds may exist in an 
immunocompromised host. The diagnosis is often clinical but 
confirmation may include histological evidence of molluscum bodies. 21 
 
 
SCABIES/PEDICULOSIS IN PREGNANCY 
No reported effect on pregnancy. 12 
 
HUMAN PAPILLOMA VIRUS INFECTION IN PREGNANCY 
Genital papilloma virus infection affects young women of 16 to 25 
years, which is also the age group with highest rate of pregnancy 
occurs.15 Genital human papilloma viral infection has the prevalence of 
20 to 40% in the sexually active women under the age of 30 years. 
True incidence of genital warts in pregnancy is uncertain. 28% of 
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individuals were seropositive for HPV 16 viral capsid antibodies. 12 
Human papilloma virus subtype 6 & 11 are most commonly 
associated with genital warts. But it may also be caused by 16 & 18 
oncogenic subtypes. 
Women appear to manifest HPV infection as symptomatic warts 
during pregnancy. Human papilloma viral infection is usually multifocal 
and most women with vulvar lesions also have cervical infection and vice 
versa.15,22 
Genital warts frequently increase in size and number during 
pregnancy and mechanically obstruct labour. Increased vaginal mucus 
secretion throughout pregnancy offers ideal moist conditions for viral 
growth and accelerated viral replication with advancing pregnancy and 
progression to cervical neoplasm. HIV infection also encourages the 
growth of warts in pregnancy. The warts may regress spontaneously in 
the postpartum period either due to loss of vascularity, excessive moisture 
or due to immunosuppression of pregnancy.22 
Transmission by ascending or transplacental route may be possible 
in the antepartum period. In the intrapartum period transmission rate is 
very low. Risk of transmission of the virus in the neonatal oropharynx is 
30%. 12, 55   But the virus was cleared by 5 weeks.  
Occasionally baby develops genital, perigenital or perianal warts or 
papillomas of respiratory mucosa. Perinatal transmission during vaginal 
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delivery is the likely mode of spread, since the child borne of caesarean 
section seems to have lower risk of acquiring recurrent respiratory 
papillomatosis. 12,56 But caesarean delivery is not entirely found to be 
protective against juvenile onset recurrent respiratory papillomatosis 
[JORRP]. 57 
The clinical appearance of genital warts is characteristic but 
histopathology is confirmatory.22 
 
HUMAN IMMUNODEFICIENCY VIRUS INFECTION IN 
PREGNANCY 
HIV and AIDS epidemic continues to advance at an alarming rate 
in India. Over 5 million individuals are already infected with HIV & 
AIDS and women constitute 1.5 million and 84% of these women are in 
the child bearing age group of 15 to 45 years.58 
Screening women for antibody to HIV in various geographic areas 
throughout the world has shown the seroprevalence to be from 0.5 to 
20%. 59 
In western countries HIV-1 seroprevalence among women of child 
bearing age is generally under 1%, wheras in  developing countries the 
seroprevalence among pregnant women can be as high as 32% and about 
1600 infected infants are born daily. Every year approximately 20,000 
deliveries are likely to be conducted in seropositive Indian mothers. 
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Surveillance data of HIV infection among antenatal mothers by 
NACO in Tamil Nadu was 0.64% and the seroprevalence of HIV 
infection was in the range of 0.5 to 3.3%. 60 
Prevalence is said to be on rise and no longer confined to high risk 
population group. Prevalence of HIV infection among STD clinic 
attendees in Tamil Nadu is 8.4%.60 About 89% of pediatric HIV infection 
occurs by mother to child transmission. 
It is estimated that in India almost 30% of HIV infection occurs in 
those women who have sexual intercourse with a single male partner. 
Many women who delivered an infant who subsequently develops AIDS 
have been asymptomatic during pregnancy.61 But it is noted that 
seropositive pregnant women have increased incidence of infections such 
as gastroenteritis, pyelonephritis, pneumonia, and cellulites as 
complication.62 
Ulcerative STIs increase the risk of acquiring HIV infection by 10 
fold and genital discharges increases the risk by 5 fold. 
 Male to female transmission is 17 times higher than female to 
male transmission. Younger women’s immature cervix, relatively low 
vaginal mucous production and larger surface area of mucosa exposed 
during intercourse and higher viral concentration favours male to female 
transmission. 63 
For HIV infected women it is unknown whether pregnancy by 
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itself or possibly along with certain cofactors such as genitourinary 
infection increases the rate of progression to AIDS. Immuno suppression 
including fall in CD-4 lymphocyte count allow extended viral replication 
and disease progression. In addition antigenic stimulation of fetal tissues 
during pregnancy could lead to T cell activation and viral replication. 
According to certain studies in seropositive mothers there has been 
high incidence of premature rupture of membranes, preterm labour, 
intrauterine fetal death, low birth weight and higher neonatal death rate 
which increase further with co-existing STIs.  
Rupture of membranes, chorioamnionitis and other maternal STIs 
favours transmission of HIV infection to the fetus.,21,64 Adverse 
pregnancy outcomes are associated with CD-4 count proportion less than 
14%. 
The rate of vertical transmission of HIV from mother to the fetus 
varies between 15 to 48%. Transplacental transmission can occur as early 
as 8 weeks of gestation. The risk factors associated with transmission are 
low CD-4 count , decreased CD-4 : CD-8 ratio, plasma viremia, p24 
antigen levels, high viral copy number, AIDS defining 
illness/symptomatic disease in the mother, placental membrane 
inflammation, prematurity, prolonged breast feeding.62,65 
Few studies show increased risk with female gender of the infant, 
higher maternal age, maternal vitamin A deficiency, premature rupture of 
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membranes for more than 4 hours, smoking and drug abuse. The presence 
and amount of virus in the genital tract may affect transmission risk.66 
Transmission of virus from the mother to infant may occur during 
gestation by crossing the placenta, during delivery by contact with 
maternal blood and body fluids and post partum via breast feeding.66 
Studies show inconsistent results that whether women with 
monocytotrophic HIV strains or T cell line tropism viruses are more 
likely to transmit the disease to the offspring.67 
Intra partum transmission is thought to account for more than half 
of perinatal infections. The risk of transmission is most likely in the third 
trimester and at the time of labour. Absolute risk of in utero transmission 
is 5 to 6% and intra partum is 13 to 48% and via breast feeding is 16%. 68 
The newborns immature gastro intestinal system with low gastric 
acidity, thin mucosa and microvilli facilitate HIV transmission. 
So the best way to prevent maternal to child transmission is by offering 
integrated  counselling and testing services to all antenatal women. 58 
 
 
 
 
 
 28
AIMS AND OBJECTIVES 
 
1. To determine the prevalence of sexually transmitted infections 
including HIV among the pregnant women. 
    2.   To study about the age distribution, socio economic status and 
     Educational level of the pregnant women. 
3. To study the prevalence of concomitant sexually transmitted           
      infections among the pregnant women. 
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MATERIALS AND METHODS 
 
NATURE OF THE STUDY 
 It is a prospective observational study to find out the prevalence of 
STIs among the pregnant women attending the STD outpatient 
department at the Institute of Venereology, Government General 
Hospital, Chennai from January 2006 to June 2007. 
MATERIALS 
Out of 140 pregnant women attending STD outpatient department 
at Institute of Venereology, Government General Hospital, Chennai, 90 
pregnant women was found to have sexually transmitted infections. 
Majority of the pregnant women were referred from Institute of 
Obstetrics and Gynecology, Egmore, Chennai and Kasthuriba Gandhi 
Hospital for Women and Children, Triplicane, Chennai, Corporation 
Hospitals and other Hospitals. Pregnant women were referred for VDRL 
reactivity. Also many attended on their own for various genitourinary 
symptoms. 
Unmarried pregnant women were brought from vigilance home to 
screen for sexually transmitted infections including HIV infection. 
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METHODS 
A well structured proforma was prepared and used for the study. It 
consists of various informations including their age, socio economic 
status, marital status, sexual history and obstetric history apart from 
detailed clinical examination. Pregnant women were screened for 
sexually transmitted infections and a provisional diagnosis was made. 
Routine and special investigations were done accordingly to confirm the 
diagnosis. 
SPECIMEN COLLECTION 
Vaginal discharge was examined after adding one drop of normal 
saline for wet mount and 10% potassium hydroxide one drop is added  for 
KOH mount and for Whiffs test. pH of the discharge was noted.  
Discharge was also smeared on glass slide for Gram stain. 
In case of genital ulcer, after thorough cleaning of ulcer, serous 
exudate was used for dark field microscopy. Smear was taken from the 
base of the ulcer for Tzanck smear and Gram staining was also done. 
Tissue smear was taken and stained with leishman’s stain for Klebsiella 
granulomatis. 
 
 
 
MICROSCOPY 
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Wet mount Examination 
This is a simple diagnostic procedure used to visualize normal 
epithelial cells, motile trichomonads, clue cells, pus cells and also 
candidal hyphae in some cases.  
KOH Mount  
This test is used for the diagnosis of genital candidiasis. Addition 
of pottasium hydroxide to vaginal discharge gives fishy amine odour in  
bacterial vaginosis. 
 
Gram stain 
A thin smear was prepared on a clean glass slide by rolling the 
swab on the slide. After air drying and heat fixing the smear, it was 
stained with gram stain. Smear was examined under microscope to look 
for the presence of epithelial cells, polymorphonuclear leucocytes and the 
intracellular and extracellular gram negative diplococci, clue cells of 
bacterial vaginosis, candidal hyphae and spores and streptobacilli in 
school of fish appearance. 
Dark field Examination  
Treponema pallidum is demonstrated from moist lesions of 
primary, secondary syphilis using dark field examination. Clear serous 
exudate from the lesion is obtained on a glass slide after cleaning the 
lesion using physiological saline and abrading the lesion with dry gauze. 
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This slide is examined immediately under dark field microscope. 
 
Tzanck smear 
This smear can be used for the diagnosis of genital herpes. 
Scrapings from the vesicle, base of the ulcer was stained with Leishman’s 
and examined for the presence of multi nucleated giant epithelial cells. 
 
Culture of Candida species 
Sabouraud’s Medium is the commonest fungal culture media used. 
It consists of ingredients like glucose, cycloheximide, agar etc. Sterile 
vaginal swabs were used for taking specimens, cultures were incubated at 
room temperature for 2 weeks. 
Identification is based on the colony appearance (creamy, white 
and mucoid) and the morphology of the fungus by microscopy. The 
method of identifying Candida albicans was based on the ability to form 
germ tubes within two hours when incubated in human serum at 37ºС.  
 
SEROLOGY  
Blood samples were collected for VDRL test, Trepenonema 
pallidum haemagglutination test, for detection of Hepatitis B surface 
antigen by Enzyme Linked ImmunoSorbent Assay and for detection of 
HIV specific antibodies by ELISA. HIV Positive patients were registered 
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in well health clinic and CD-4count along with investigations for 
opportunistic infections were done. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
RESULTS 
In this study, 90 pregnant women were examined and following 
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results were obtained. 
1. AGE DISTRIBUTION 
Table No: 1 – Age distribution of pregnant women (n=90) 
Age group in years Total No. Percentage 
16 -20 27 30 
21-25 42 46.7 
26-30 14 15.6 
31-35 4 4.4 
Above 35 3 3.3 
 
Majority of the pregnant women were in the age group of 21-
25years (46.6%). The youngest and oldest pregnant women encountered 
in the study were aged 17 and 39 respectively.  
 
2. EDUCATIONAL STATUS 
Table No: 2 – Educational status of pregnant women (n=90)  
Education Total No. Percentage (%) 
Uneducated 13 14.4% 
Upto 5th 21 23.3% 
Upto 10th 39 43.3% 
+1 &+2 14 15.6% 
College 3 3.3% 
 
Majority of the pregnant women studied upto 10th standard 
(43.3%). Only 3 women obtained degree (3.3%). 
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3. SOCIO-ECONOMIC STATUS 
Table No: 3 - Socio-economic status of pregnant women (n=90)  
Monthly Income Total No. Percentage (%) 
Up to 1000 51 56.6% 
1000-2000 29 32.2% 
2000-3000 6 6.7% 
Above 3000 4 4.4% 
 
Majority of the pregnant women belonged to lower socio-economic 
strata (56.7%), i.e. income less than Rs.1000/month. 
 
4. MARITAL STATUS 
Table No:4 – Marital status of the pregnant women (n-90) 
Marital status Total No. Percentage (%) 
Married 85 94.4% 
Single (unmarried) 5 5.6% 
 
Majority of the pregnant women were married (n=85, 94.4%).  
 
 
 
5. REFERENCE  
Table No: 5 – Referral status of the pregnant women (n=90)  
Reference Total No. Percentage (%) 
IOG 32 35.6 
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KGH 7 7.8 
Other Hospitals 28 31.1 
Self 8 8.9 
Contact sake 7 7.8 
Vigilance Home 6 6.7 
NGO 2 2.2 
 
Majority of the pregnant women were referred from Institute of 
Obstetrics and Gynecology (35.6%), and also from other hospitals like 
Kasthuriba Gandhi hospital (7.8%) and from corporation hospitals. Few 
attended STD outpatient department on their own for genital complaints 
(8.9%) and for contact sake (7.8%).  
 
6. DURATION OF PREGNANCY 
Table No: 6 – Duration of pregnancy among women (n=90) 
Trimester Total No. Percentage (%) 
First 16 17.8 
Second 41 45.5 
Third 33 36.7 
 
Majority of the pregnant women were in the second trimester (45.5%). 
 
 
7. PRESENTING COMPLAINTS 
Table No: 7 – Presenting complaints of pregnant women (n=90)  
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Complaints Total No. Percentage (%) 
Check up 32 35.6 
Genital discharge 22 24.4 
Soreness of genitalia 15 16.7 
Itching in Genitalia 14 15.6 
Growth in genitalia 12 13.3 
Ulcer in genitalia 9 10 
Swelling in genitalia 8 8.9 
Burning micturition 4 4.4 
Lower abdominal pain 1 1.1 
 
Majority of the pregnant women had visited the STD outpatient 
department for check up (35.5%). Some pregnant women attended the 
outpatient department with multiple complaints.  Genital discharge 
(24.4%) and soreness of genitalia (16.7%) were the most common  
presenting complaints, followed by itching in the genitalia (15.6%), ulcer 
in the genitalia (10%) and growth in the genitalia (13.3%). Some 
pregnant women also had other symptoms like burning micturition 
(4.4%), and lower abdominal pain (1.1%).  
 
 
 
8. SEXUAL HISTORY 
Table No: 8 – Premarital / extramarital contacts among married 
Pregnant women (n=85) 
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Contacts Total No. Percentage (%) 
Only MC 75 88.4 
MC  +  EMC 6 7 
PMC + MC 3 3.5 
PMC + MC + EMC 1 1.1 
 
  When married pregnant women were interwieved for this study, 
around 7% gave the history of extramarital contact (n=6) and 3.5% gave 
the history of premarital contact (n=3). One woman gave history of both 
premarital and extramarital contact.  
 
9. STATUS OF UNMARRIED PREGNANT WOMEN 
Table No: 9 – Status of the unmarried pregnant women (n=5) 
Group Total No. Percentage (%) 
C.S.W. 3 60 
Kept 1 20 
Deserted 1 20 
 
In the women who were unmarried, majority were commercial sex 
workers with history of multiple partners (n=3, 60%). One woman was 
kept mistress (20%). 
 
10.PAST HISTORY OF SEXUALLY TRANSMITTED INFECTION 
Table No: 10 – Past history of STIs (n=90) 
Past H/O STIs Total No. Percentage (%) 
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Present 8 8.8 
Absent 82 91.1 
 
Table No: 11 – Distribution of previous STIs (n=8) 
Disease Total No. Percentage (%) 
Discharge 4 50 
Wart 2 25 
Ulcer 2 25 
 
Among the 8 pregnant women who gave the past history of STI, 4 
had genital ulcer (50%), 2 had genital discharge (25%), and 2 gave 
history of warts (25%). 
11. BAD OBSTETRIC HISTORY (BOH) 
Table No: 12 – BOH among the pregnant women (n=17)  
BOH Total No. Percentage (%) 
Spontaneous abortion 5 29.4 
Neonatal death 3 17.6 
Preterm labour 2 11.8 
Abortion +IUD 3 17.6 
Abortion + Preterm 2 11.8 
IUD 1 5.8 
Low Birth Weight 1 5.8 
 
Bad obstetric history was found in 17 patients (18.8%) out of 90 
pregnant women screened in the study. Majority of them had spontaneous 
abortion (29.4%), followed by neonatal death in 3 patients (17.6%), 
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preterm labour (11.8%). Three women (17.6%)  had both spontaneous 
abortion and intrauterine death (IUD) and only one women had low birth 
weight (5.8%). 
12. CLINICAL SIGNS 
Table No: 13 – Clinical signs in the pregnant women (n=90) 
Clinical sign Total No. Percentage (%) 
Soddening of vulva 20 22.2 
Genital wart 18 20 
Genital ulcer 13 14.4 
Odema of vulva 4 4.4 
Bilateral inguinal lymphadenopathy 3 3.3 
 Bartholin’s cyst 3 3.3 
Excoriations of vulva 1 1.1 
Molluscum contagiousum 1 1.1 
Condylomata lata 1 1.1 
Furunculosis of Vulva 1 1.1 
Intertrigo groin 1 1.1 
Tinea cruris 1 1.1 
 
Soddening of Vulva was the most common clinical sign seen in 21 
women (22.2%). Genital wart was the next common sign seen in 18 
women (20%), followed by genital ulcer (14.4%). Out of 14 women with 
genital ulcer, one had single painless ulcer suggestive of chancre, eight 
women had multiple painful superficial ulcers of herpes genitalis and 
others had linear superficial fissures suggestive vulvovaginal candidiasis. 
Bartholin’s cyst was seen in 3 women (3.3%), molluscum contagiosum 
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lesion was seen in one women(1.1%). Genital warts were distributed over 
labia majora, labia minora, fourchette. 
 
Table No : 14 – Nature of genital discharge (n=90) 
 Nature of discharge Total No. Percentage (%) 
          Mucoid 42 46.7 
Mucopurulent 26 28.9 
          Curdy white 21 23.3 
           Frothy 1 1.1 
 
Majority of pregnant women had mucoid discharge (46.7%). 
13. RESULTS OF INVESTIGATION IN THE STUDY GROUP 
  Table No : 15 - Results of investigation (n=90) 
Investigations Positive results 
(T l N )
Percentage (%) 
Culture for candida spp. 27 30 
Gram stain for candida 23 25.6 
KOH mount for candida 21 23.3 
Gram stain for clue cells 18 20 
Tzanck smear for GEC 8 8.9 
Wetmount 4 4.4 
DF for Treponema 2 2.2 
 
Smear for gonococcus and culture for gonococcus were negative in 
all pregnant women in the study. 
Vaginal discharge for culture of candida species in sabouraud’s 
dextrose agar medium revealed growth in 27 cases (30%). Clue cells were 
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demonstrated by wet mount and gram stain in 18 women (20%), and 
Tzanck smear shows giant epithelial cells in 8 women (8.9%), wet mount 
shows trichomonas vaginalis in 4 patients (4.4%) and treponema pallidum 
was demonstrated by dark field microscopy in 2 patients (2.2%). 
14. SEROLOGY RESULTS AMONG THE PREGNANT WOMEN 
Table No: 16 - – Prevalance of VDRL   Reactivity (n=90) 
Serological test Patients with reactive serology Percentage(%)
VDRL 16 17.7 
 
Blood VDRL was reactive in 16 (17.7%) patients and non reactive 
in 74 (82.2%) patients. 
Table No: 17 – Distribution of VDRL titer (n=16) 
VDRL Titer Total No. Percentage (%) 
1 dilution 3 18.8 
2 dilution 3 18.8 
4 dilution 6 37.5 
16 dilution 1 6.2 
32 dilution 2 12.5 
64 dilution 1 6.2 
 
One Woman with secondary syphilis have VDRL reactive in 64 
dilutions (6.2%). VDRL was reactive in 4 dilutions in 6 (37.5%) patients. 
 
Table No : 18 – Prevalance of TPHA Reactivity (n=90) 
Serological test Patients with reactive serology Percentage(%)
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TPHA 16 17.7 
 
Blood TPHA was reactive in 16 (17.7%) patients and non reactive 
in 74 (82.2%) patients. 
 
Table No : 19– Prevalence of HBs Ag (n=90) 
Serological test Patients positive for HBs Ag Percentage (%) 
HBs Ag 2 2.2 
 
ELISA test for Hepatitis B surface antigen was positive in only 2 
patients (2.2%). It was negative in 88 Patients (97.8%).  
 
Table No : 20– Prevalence of HIV infection (n=90) 
Serological test Patients positive for HIV Percentage (%) 
HIV 6 6.7 
 
Out of 90 pregnant women, 6 women (6.7%) were found 
seropositive and 84 women (93.3%) were negative for HIV anti bodies. 
 
15. INFECTIONS DIAGNOSED BY CLINICAL EXAMINATION 
AND INVESTIGATIONS IN THE STUDY GROUP  
Table No : 21 – Distribution of infections among pregnant 
women(n=90) 
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Infections Total no. Percentage (%) 
Vulvovaginal candidiasis 27 30 
Genital wart 18 20 
Bacterial vaginosis 18 20 
Syphilis 16 17.8 
Genital herpes 8 8.9 
HIV 6 6.7 
Trichomonas vaginalis 4 4.4 
Bartholins cyst 3 3.3 
Non-gonococcal urethritis 4 4.4 
Hepatitis-B 2 2.2 
Molluscum contagiosum 1 1.1 
 
Out of 16 patients with syphilis, one had primary syphilis (6.2%), 
one had secondary syphilis (6.2%), 12 had early latent syphilis (75%) and 
two had late latent syphilis (12.5%). 
 
Table No : 22 – Infection among unmarried pregnant women (n=5) 
Infections Total No. Percentage (%) 
Trichomonas vaginalis 2 40 
Syphilis 1 20 
Bacterial vaginosis 1 20 
Vulvovaginal Candidasis 1 20 
 
Among the unmarried pregnant women (n=5) 2 had trichomonas 
vaginalis infection (40%), and one woman had primary syphilis (20%). 
Table No: 23 – Infection among HIV positive pregnant women (n=6) 
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Infections Total No. Percentage (%) 
Genital wart 2 33.3 
Bacterial vaginosis 1 16.7 
Vulvovaginal candidiasis 1 16.7 
Molluscum contagiosum 1 16.7 
 
  Among the 6 HIV positive pregnant women examined and 
investigated 5 had single or multiple infections. Vulvovaginal candidiasis 
was found in one woman (16.7%), two women had genital wart, (33.3%) 
and molluscum contagiosum in one woman (16.7%). 
 
16. DISTRIBUTION OF INFECTION AMONG HUSBANDS OF 
MARREID PREGNANT WOMEN 
Table No: 24 – Infections among husbands of married pregnant 
women (n=37) 
Infections Total No. Percentage (%) 
Genital wart 13 35.1 
Syphilis 9 24.3 
HIV 6 16.2 
Genital herpes 5 13.5 
Candidiasis 2 5.4 
Among the husbands (n=35) examined and investigated, thirteen 
had genital wart (35.1%), nine had early latent syphilis (24.3%) and five 
had genital herpes (13.5%). 
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17. CONCOMITANT INFECTIONS IN THE STUDY GROUP OF 
PREGNANT WOMEN 
Table No : 25  Concomitant infections in the study group (n=90) 
 
Infections Total No. Percentage(%)
Candidiasis + Genital herpes 2 22.2 
Candidiasis + Bartholins cyst 2 22.2 
Candidiasis + Bacterial vaginosis 2 22.2 
Candidiasis + Bacterial vaginosis 1 11.1 
Candidiasis + Bacterial vaginosis +TV 1 11.1 
Candidiasis + HIV 1 11.1 
Bacterial vaginosis + Genital wart 1 11.1 
Bacterial vaginosis +Syphilis 1 11.1 
Bacterial vaginosis + Hepatitis-B 1 11.1 
Bacterial vaginosis + HIV 1 11.1 
Trichomonas vaginalis + Genital 1 11.1 
Trichomonas vaginalis + Syphilis 1 11.1 
HIV +  Genital wart 1 11.1 
HIV + Molluscum contagiosum 1 11.1 
 
 
 
 
DISCUSSION 
 
In this study, majority of the pregnant women were in the age 
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group of 21-25(46.7%), followed by 16-20 years of age. A significant 
number of pregnant women were below 20 years. This study has 
confirmed that adolescent sexual activity has increased resulting in rise in 
unintended pregnancy rate. Due to early initiation of sexual activity, they 
are more prone for STIs including HIV. As they often resort to Medical 
Termination of Pregnancy, services offered to them should include check 
up for sexually transmitted diseases and knowledge about contraception. 
Majority of the pregnant women belonged to lower socio-economic 
strata. Lower socio-economic status often co-exists with poor nutritional 
status of pregnant women which in turn affect the course of the disease 
and their obstetric outcomes. 
Majority of the pregnant women in this study were married 
(94.4%). A considerable number of pregnant women were unmarried. 
They form an important risk group for acquiring STIs including HIV 
infection. 
Majority of the pregnant women were reffered to the STD 
outpatient department for VDRL reactivity and genital lesions.  A good 
number pregnant woman presented with various genitourinary symptoms 
on their own along with their partners. This increase in number of self 
referral by these women could be as a result of awareness about sexually 
transmitted infections including HIV.  
Nearly one third of the pregnant women reported only for check 
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up. However on clinical examination and completion of investigations, it 
was found that they were suffering from one or other infections. This 
shows that majority of the pregnant women were asymptomatic. Among 
the asymptomatic pregnant women (n=28), 11 were found to be affected 
with early latent syphilis, 8 with bacterial vaginosis, 2 with Hepatitis-B, 
and 2 with HIV infection.   
The significance of this is that pregnant women may not be aware 
of the silent clinical status of syphilis, Hepatitis-B and HIV. This may 
lead to delay in detection, progression of the disease to complications and 
vertical transmission. Early diagnosis by routine antenatal screening for 
STIs will greatly help in the detection in the initial stages so that effective 
interventions can be done. 
Genital discharge, genital soreness and itching genitalia were the 
most common symptoms noted among the study group. 
Majority of the married pregnant women denied history of 
premarital or extramarital contacts (88.4%). This stresses the fact that 
innocent housewives were infected by their promiscuous husbands and 
were exposed to high risk of acquiring STIs including HIV infection 
resulting in morbidity and mortality. Their unborn and newborn children 
were also at risk. 
Genital discharge (50%) was the commonest among previous 
venereal diseases noted. There is an increased rate of recurrence of genital 
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herpes during pregnancy.11, 12 
Bad obstetric history was noted in a significant proportion of 
pregnant women (18.8%). Majority of them had spontaneous abortion in 
the past followed by neonatal death. Among these women (n=17), 
majority were found to have syphilis (n=5, 29.5%). The other STIs noted 
were Bacterial vaginosis (n=4, 23.5%), HIV (n=2, 11.8%), Genital herpes 
and trichomonas infection. 
In this study group, soddening of vulva, genital warts and genital 
ulcer were the most important clinical signs noted. 
Generalised lymphadenopathy is an important sign of secondary 
syphilis and HIV disease. Among the pregnant women, one had 
generalized lymphadenopathy (1.1%). She was found to have HIV 
infection. 
Moist grayish white, flat topped papules which are highly infective 
in nature were seen in one pregnant woman. Untreated maternal 
secondary syphilis carries high risk of perinatal complications. 
In this study group 6 cases were found to HIV seropositive. These 
women were screened to detect signs of AIDS defining illnesses early. 
In this study, mucopurulent vaginal discharge was most commonly 
seen. Patients with Bacterial vaginosis (n=18) and Trichomonas vaginalis 
vaginitis had predominantly mucopurulent discharge and typical frothy 
vaginal discharge of Trichomoniasis was seen in only one woman. 
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The usual description of discharge in vulvovaginal candidiasis is 
curdy white and adherent. In this study group 77.7% of the pregnant 
women had above said clinical sign and remaining had only itching in 
genitalia. Culture for gonococcus was negative in the study group. 
About 30% of the pregnant women had genital candidiasis. This 
study confirmed the aspect that vulvovaginal candidiasis is more common 
in pregnancy. Vulvovaginal candidiasis co-existed with many other STIs 
in this study.  
The prevalence of VDRL/TPHA reactivity was 17.7%. This is 
comparable with prevalence rate of syphilis in STD clinic attendees is 17-
30% and the prevalence is between 3-19% in developing countries. 
The prevalence of Genital wart in the group of pregnant women in the 
study was 20%. This high prevalence data could be due to high risk 
population group screened. 56 
The prevalence of Bacterial vaginosis in this study population is 
20%. This is comparable with prevalence rate of 12 to 23 % in pregnant 
women in India. 45 
The prevalence of Genital herpes in the study population is 8.9%. 
This high prevalence data could be due to high risk population group 
screened. 
In this study group, prevalence of HIV was 6.5% which was 
relatively higher than some Indian studies.61 This could be due to 
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screening of high risk population in the study. 
The prevalence of HBs Ag in the study group was 2.2%. This was 
comparable with Risbund, et al study from Chandigarh. 27 
Prevalence of Trichomoniasis in the study population was 4.4%.This was 
comparable with 6% prevalence of Divekar AA, et al study from 
Mumbai.12 
The most important sexually transmitted infections found in 
unmarried pregnant women (n=5) were Trichomoniasis (40%), Bacterial 
vaginosis (20%), Syphilis (20%), candidiasis (20%). This prevalence data 
is higher than married pregnant women. 
Among the HIV positive pregnant women in this study group, viral 
STIs were found to be more common than bacterial STIs, which is 
consistent with other studies. 35 
Health education regarding transmission of sexually transmitted 
infection, safer sex and counselling should be made available to them. 
Prompt treatment of infected person and their partners by early detection 
will prevent further transmission. It will also minimize the severity of 
long term sequelae. 
The larger number of pregnant women with an STI provides an 
important opportunity to reduce the reservoir of infection in the broader 
community. Hence systematic screening of sexually transmitted infection 
in pregnancy combined with adequate treatment and follow up will 
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reduce the risk of maternal, fetal and neonatal adverse consequences. 
Appropriate antenatal, intrapartum and postnatal care should be provided. 
Unmarried pregnant women have an increased risk of acquiring 
STIs, hence counselling services, knowledge regarding use of 
contraceptives and provision of STI care should be made available to 
them. 
Sexually transmitted infections often coexist and a search for them 
should be instituted in every patient.  
 
 
 
 
 
 
CONCLUSION 
• Vaginal discharge was more common than genital ulcer 
diseases. Vulvovaginal candidiasis (30%) was the commonest 
STI among the pregnant women, followed by Genital      wart 
(20%), Bacterial  vaginosis (20%) and syphilis(17.8%).  
• HIV infection was prevalent in 6 pregnant women (6.7%). 
• Hepatitis B was prevalent in 2 pregnant women (2.2%). 
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• Around 88.8% of the pregnant women belong to the lower socio 
economic status i.e., less than Rs.2000/- per month. Nearly 
76.7% of pregnant women belong to the age group of 16 - 
25years.  
• Nearly 83.4% of the HIV infected pregnant women were 
affected with other sexually transmitted infections. Genital wart 
was the commonest viral infection among HIV infected 
pregnant women (33.3%).  
• Vulvovaginal candidiasis was coexisting with multiple STIs 
among pregnant women.  
Routine screening for sexually transmitted infections in all 
pregnant women should be included in the antenatal care. Effective 
treatment services should be made widely available for those who are 
found to be infected.  
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PROFORMA 
1. Serial No.                                     2. STD OP No. 
3. Name                                            4.Age 
5. Educational qualification: Uneducated/<5th/<10th/+1&+2/college 
6. Income: <1000/1000-2000/2000-3000/>3000 
7. Marital status &Duration of marriage 
8. Occupation                                    9.Address 
10. Referred by: IOG/ KGH/Self/others 
11. Presenting complaints: 
        Duration of amenorrhoea 
        Genital ulcer with duration –Single/Multiple  Painful/Painless 
        Genital discharge with duration – foul smelling/not  
        Itching genitalia 
        Swelling in the inguinal region –Painful/not 
        Skin rash 
        Growth in the genitalia 
        Burning micturition 
        Lower abdominal pain 
        Jaundice/ oral lesion/ fever/ joint pain/ CNS disturbances 
12. Obstetric History: 
         Months of amenorrhoea                      LMP:              EDD: 
          Gravida/ Para 
         Previous obstetric H/O – Sex /Age/Mode of delivery 
         Menstrual H/O – Regular/ Irregular 
13. Treatment History: 
         Treatment taken for present complaints 
         History of previous venereal disease and treatment 
14. Exposure History: 
         Recent exposure with dates MC:             PMC:             EMC: 
15. Contact History: 
               Partner name and card No.                      
               History and investigations report 
16. Examination:  
          General and systemic examination 
          Examination of genitalia 
                Inguinal nodes 
                External urethral meatus 
                Speculum examination 
                Genital lesion – Soddening of vulva/ wart/ ulcer 
                Discharge – Scanty/ moderate/ profuse 
                                     Mucoid/ mucopurulent/ purulent 
                                     Homogenous/ flocullar/ curdy 
                                     Foul smelling/ not  
           Other systems – Skin and mucous membrane          
                                          Bones and joints 
17. Investigations:   
         Wet mount -   Saline 
                                  KOH 
              Smear          -      Urethral/Cervical/Vaginal 
         Culture        -      Gonococci/Candida/General microbial culture 
         Ulcer           -       Dark field for treponema 
                                     Gram stain for Hemophilis ducrey 
                                     Leishman stain for gaint epithelial cells 
                                     Tissue smear for Calymmatobacterium  -  
                                      granulomatis  
         VDRL & TPHA 
         USG Abdomen 
         VCTC 
          Hep B  
          HCV 
          Urine Routine and Culture sensitivity 
          Complete hemogram 
          Random blood sugar 
